investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mechanistic basis of allogeneic IgG-induced tumor eradication
Ian Lisle Linde
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Dean W Felsher
Modeling and Predicting Therapeutic Resistance of Cancer
Melanoma of skin
Benjamin Raphael
Computational Characterization of Genetic Heterogeneity
Melanoma of skin
Jeffrey Lee
Genetic Mechanisms of Immunity and Inflammation in Mmelanoma Progression
Melanoma of skin
Pathology
Andrew Gregory Sikora
TARGETING INOS TO INHIBIT MYELOID-DERIVED SUPPRESSOR CELLS (MDSC) IN MELANOMA
Melanoma of skin
Patrick J. Loehrer
Indiana University Melvin and Bren Simon Cancer Center Support Grant
Melanoma of skin
Palliative Care
Eva Hernando
Prognostic and Functional Role of microRNAs in Melanoma Brain Metastasis
Melanoma of skin
Pathology
Hui-Kuan Lin
Identification of a new strategy for cancer therapy
Melanoma of skin
Carl D Novina
(PQD1) Evolution of Vemurafenib Resistance in Circulating Melanoma Cells
Melanoma of skin
Pathology
Allan Weissman
Determining the Fate of Transmembrane Proteins
Melanoma of skin